<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02310256</url>
  </required_header>
  <id_info>
    <org_study_id>2011/2533/REK midt</org_study_id>
    <nct_id>NCT02310256</nct_id>
  </id_info>
  <brief_title>A Clinical Trial on the Effects of Home-based Five Plus Exercise Training</brief_title>
  <official_title>A Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise Training</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate whether walking capacity in patients with intermittent
      claudication is improved more by home-based 5+ exercise training than by current
      recommendations of daily walking. The study will elucidate if such a potential effect is
      dependent on changes in mitochondrial respiratory capacity, blood flow or both.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>absolute walking distance (meters) as measured by 6 minute walking test</measure>
    <time_frame>8 weeks</time_frame>
    <description>treadmill 3.2 km/hour and inclination increase every 2 minute combined with 6 minute walking test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mitochondrial function measured by respirometry</measure>
    <time_frame>8 weeks</time_frame>
    <description>Oxygen consumption (pmol O2 per second per mg of wet weight tissue) measured by respirometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial bloodflow measured by plethysmography</measure>
    <time_frame>8 weeks</time_frame>
    <description>measured by plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by SF 36 and CLAU-S questionnaires</measure>
    <time_frame>8 weeks</time_frame>
    <description>assessed by SF 36 and CLAU-S questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak oxygen uptake measured by cardio-pulmonal exercise testing</measure>
    <time_frame>8 weeks</time_frame>
    <description>measured by cardio-pulmonal exercise testing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Five Plus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Five plus exercise training</intervention_name>
    <description>calf raise exercise</description>
    <arm_group_label>Five Plus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with intermittent claudication secondary to vascular insufficiency

          -  An ankle-brachial index between 0.4 and 0.9.

        Exclusion Criteria:

          -  Diagnosed with critical limb ischemia

          -  Ankle-brachial index (ABI) &gt; 0.90 or &lt; 0.4

          -  Limited exercise tolerance

          -  Warfarin or heparin usage

          -  Underwent a vascular intervention in the last 6 months

          -  Active cancer, renal- or liver disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Øivind Rognmo, phd</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department for circulation and medical imaging, NTNU</name>
      <address>
        <city>Trondheim</city>
        <state>Postboks 8905</state>
        <zip>7491</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Van Schaardenburgh M, Wohlwend M, Rognmo Ø, Mattsson E. Calf raise exercise increases walking performance in patients with intermittent claudication. J Vasc Surg. 2017 May;65(5):1473-1482. doi: 10.1016/j.jvs.2016.12.106. Epub 2017 Mar 9.</citation>
    <PMID>28285932</PMID>
  </results_reference>
  <results_reference>
    <citation>van Schaardenburgh M, Wohlwend M, Rognmo Ø, Mattsson EJR. Exercise in claudicants increase or decrease walking ability and the response relates to mitochondrial function. J Transl Med. 2017 Jun 7;15(1):130. doi: 10.1186/s12967-017-1232-6.</citation>
    <PMID>28592294</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mitochondria, muscle</keyword>
  <keyword>Exercise</keyword>
  <keyword>Blood Flow Velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

